Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52


Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.

Kozlowski PA, Aldovini A.

Curr Immunol Rev. 2019;15(1):102-122. doi: 10.2174/1573395514666180605092054.


Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration.

Chaudhary O, Narayan V, Lelis F, Linz B, Watkins M, Veazey R, Aldovini A.

PLoS Pathog. 2018 Aug 30;14(8):e1007268. doi: 10.1371/journal.ppat.1007268. eCollection 2018 Aug.


Mucosal Vaccination for Prevention of HIV Infection and AIDS.

Aldovini A.

Curr HIV Res. 2016;14(3):247-59. Review.


HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells.

Kukkonen S, Martinez-Viedma Mdel P, Kim N, Manrique M, Aldovini A.

Retrovirology. 2014 Apr 17;11:30. doi: 10.1186/1742-4690-11-30.


Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques.

Manrique M, Kozlowski PA, Cobo-Molinos A, Wang SW, Wilson RL, Martinez-Viedma Mdel P, Montefiori DC, Carville A, Aldovini A.

J Virol. 2014 Jan;88(1):212-24. doi: 10.1128/JVI.02523-13. Epub 2013 Oct 23.


Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells.

Kim N, Kukkonen S, Martinez-Viedma Mdel P, Gupta S, Aldovini A.

Blood. 2013 May 16;121(20):4090-100. doi: 10.1182/blood-2012-10-461566. Epub 2013 Mar 27.


Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.

Manrique M, Kozlowski PA, Cobo-Molinos A, Wang SW, Wilson RL, Montefiori DC, Carville A, Aldovini A.

J Virol. 2013 Apr;87(8):4738-50. doi: 10.1128/JVI.03531-12. Epub 2013 Feb 13.


Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara.

Manrique M, Kozlowski PA, Cobo-Molinos A, Wang SW, Wilson RL, Montefiori DC, Mansfield KG, Carville A, Aldovini A.

J Immunol. 2011 Mar 15;186(6):3581-93. doi: 10.4049/jimmunol.1002594. Epub 2011 Feb 11.


Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells.

Kim N, Kukkonen S, Gupta S, Aldovini A.

PLoS Pathog. 2010 Sep 16;6(9):e1001103. doi: 10.1371/journal.ppat.1001103.


Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination.

Manrique M, Kozlowski PA, Wang SW, Wilson RL, Micewicz E, Montefiori DC, Mansfield KG, Carville A, Aldovini A.

Mucosal Immunol. 2009 Nov;2(6):536-50. doi: 10.1038/mi.2009.103. Epub 2009 Sep 9.


Unsung hero Robert C. Gallo.

Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, de Maria A, de Rossi A, Dierich M, Della-Favera R, Dolei A, Douek D, Erfle V, Felber B, Fiorentini S, Franchini G, Gershoni JM, Gotch F, Green P, Greene WC, Hall W, Haseltine W, Jacobson S, Kallings LO, Kalyanaraman VS, Katinger H, Khalili K, Klein G, Klein E, Klotman M, Klotman P, Kotler M, Kurth R, Lafeuillade A, La Placa M, Lewis J, Lillo F, Lisziewicz J, Lomonico A, Lopalco L, Lori F, Lusso P, Macchi B, Malim M, Margolis L, Markham PD, McClure M, Miller N, Mingari MC, Moretta L, Noonan D, O'Brien S, Okamoto T, Pal R, Palese P, Panet A, Pantaleo G, Pavlakis G, Pistello M, Plotkin S, Poli G, Pomerantz R, Radaelli A, Robertguroff M, Roederer M, Sarngadharan MG, Schols D, Secchiero P, Shearer G, Siccardi A, Stevenson M, Svoboda J, Tartaglia J, Torelli G, Tornesello ML, Tschachler E, Vaccarezza M, Vallbracht A, van Lunzen J, Varnier O, Vicenzi E, von Melchner H, Witz I, Zagury D, Zagury JF, Zauli G, Zipeto D.

Science. 2009 Jan 9;323(5911):206-7. doi: 10.1126/science.323.5911.206. No abstract available.


Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.

Dabrowska A, Kim N, Aldovini A.

J Immunol. 2008 Dec 15;181(12):8460-77.


DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory.

Manrique M, Micewicz E, Kozlowski PA, Wang SW, Aurora D, Wilson RL, Ghebremichael M, Mazzara G, Montefiori D, Carville A, Mansfield KG, Aldovini A.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):505-19. doi: 10.1089/aid.2007.0191.


An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS.

Wang SW, Bertley FM, Kozlowski PA, Herrmann L, Manson K, Mazzara G, Piatak M, Johnson RP, Carville A, Mansfield K, Aldovini A.

AIDS Res Hum Retroviruses. 2004 Aug;20(8):846-59.


Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.

Bertley FM, Kozlowski PA, Wang SW, Chappelle J, Patel J, Sonuyi O, Mazzara G, Montefiori D, Carville A, Mansfield KG, Aldovini A.

J Immunol. 2004 Mar 15;172(6):3745-57.


Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses.

Wang SW, Noonan K, Aldovini A.

J Virol. 2004 Jan;78(2):716-23. Erratum in: J Virol. 2004 Mar;78(5):2653.


HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages.

Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, Young RA, Aldovini A.

Nat Med. 2003 Feb;9(2):191-7. Epub 2003 Jan 21.


Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants.

Krogstad P, Geng YZ, Rey O, Canon J, Ibarrondo FJ, Ackerson B, Patel J, Aldovini A.

Virology. 2002 Mar 15;294(2):282-8.


Functional analysis of the murine sarcoma virus RNA packaging sequence.

Izmailova E, Aldovini A.

J Virol. 2002 May;76(9):4643-8.


Variation in the assessment of adequacy in cervical smears.

Migliore G, Rossi E, Aldovini A, Mudu P, Alderisio M, Giovagnoli MR, Fabiano A, Morosini PL, Branca M.

Cytopathology. 2001 Dec;12(6):377-82.


[Personnel training for a population screening program for cervical carcinoma].

Branca M, Rossi E, Cedri C, Migliore G, Cedri S, Aldovini A, Leoncini L, Bonelli L, Montanari G, Navone R.

Pathologica. 2001 Jun;93(3):233-41. Italian. No abstract available.


Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.

Wang SW, Kozlowski PA, Schmelz G, Manson K, Wyand MS, Glickman R, Montefiori D, Lifson JD, Johnson RP, Neutra MR, Aldovini A.

J Virol. 2000 Nov;74(22):10514-22.


Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins.

Jabbar IA, Fernando GJ, Saunders N, Aldovini A, Young R, Malcolm K, Frazer IH.

Vaccine. 2000 May 8;18(22):2444-53.


The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.

Leung NJ, Aldovini A, Young R, Jarvis MA, Smith JM, Meyer D, Anderson DE, Carlos MP, Gardner MB, Torres JV.

Virology. 2000 Mar 1;268(1):94-103.


Impact of the Pathfinder in a cytology laboratory.

Coggi G, Bulfamante G, Romeo M, Falleni M, Aldovini A, Cirillo G, Federico D, Roncalli M.

Acta Cytol. 1997 Jan-Feb;41(1):166-72.


Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.

Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, Eisen HN.

J Exp Med. 1994 Oct 1;180(4):1283-93.


Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes.

O'Donnell MA, Aldovini A, Duda RB, Yang H, Szilvasi A, Young RA, DeWolf WC.

Infect Immun. 1994 Jun;62(6):2508-14.


The uraA locus and homologous recombination in Mycobacterium bovis BCG.

Aldovini A, Husson RN, Young RA.

J Bacteriol. 1993 Nov;175(22):7282-9.


Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.

Aldovini A, Young RA.

Nature. 1991 Jun 6;351(6326):479-82.


New AIDS vaccine candidates: antigen delivery and design.

Aldovini A, Young RA, Palker TJ.

AIDS. 1991;5 Suppl 2:S151-8. Review. No abstract available.


Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity.

Yamamoto H, Miller MD, Tsubota H, Watkins DI, Mazzara GP, Stallard V, Panicali DL, Aldovini A, Young RA, Letvin NL.

J Immunol. 1990 May 1;144(9):3385-91.


Development of a BCG recombinant vehicle for candidate AIDS vaccines.

Aldovini A, Young RA.

Int Rev Immunol. 1990;7(1):79-83. Review. No abstract available.


Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.

Walker BD, Flexner C, Birch-Limberger K, Fisher L, Paradis TJ, Aldovini A, Young R, Moss B, Schooley RT.

Proc Natl Acad Sci U S A. 1989 Dec;86(23):9514-8.


Envelope sequences of two new United States HIV-1 isolates.

Gurgo C, Guo HG, Franchini G, Aldovini A, Collalti E, Farrell K, Wong-Staal F, Gallo RC, Reitz MS Jr.

Virology. 1988 Jun;164(2):531-6.


Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status.

Franchini G, Robert-Guroff M, Aldovini A, Kan NC, Wong-Staal F.

Blood. 1987 Feb;69(2):437-41.


HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Feinberg MB, Jarrett RF, Aldovini A, Gallo RC, Wong-Staal F.

Cell. 1986 Sep 12;46(6):807-17.


Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.

De Rossi A, Franchini G, Aldovini A, Del Mistro A, Chieco-Bianchi L, Gallo RC, Wong-Staal F.

Proc Natl Acad Sci U S A. 1986 Jun;83(12):4297-301.


The trans-activator gene of HTLV-III is essential for virus replication.

Fisher AG, Feinberg MB, Josephs SF, Harper ME, Marselle LM, Reyes G, Gonda MA, Aldovini A, Debouk C, Gallo RC, et al.

Nature. 1986 Mar 27-Apr 2;320(6060):367-71.


Immortalization of human T lymphocytes by HTLV-I: phenotypic characteristics of target cells and kinetics of virus integration and expression.

Del Mistro A, De Rossi A, Aldovini A, Salmi R, Chieco-Bianchi L.

Leuk Res. 1986;10(9):1109-20.


Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: evidence for a doubly spliced x-lor mRNA.

Aldovini A, De Rossi A, Feinberg MB, Wong-Staal F, Franchini G.

Proc Natl Acad Sci U S A. 1986 Jan;83(1):38-42.


trans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor protein.

Sodroski JG, Goh WC, Rosen CA, Salahuddin SZ, Aldovini A, Franchini G, Wong-Staal F, Gallo RC, Sugamura K, Hinuma Y, et al.

J Virol. 1985 Sep;55(3):831-5.


Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphoma virus type I: parameters of virus integration and expression.

de Rossi A, Aldovini A, Franchini G, Mann D, Gallo RC, Wong-Staal F.

Virology. 1985 Jun;143(2):640-5.


Supplemental Content

Loading ...
Support Center